Detalhe da pesquisa
1.
Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials.
Lancet;
402(10411): 1434-1448, 2023 10 21.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37865470
2.
The Risk of Optic Neuritis following mRNA Coronavirus Disease 2019 Vaccination Compared to Coronavirus Disease 2019 Infection and Other Vaccinations.
Ophthalmology;
2024 Feb 24.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38408705
3.
Faricimab for neovascular age-related macular degeneration and diabetic macular edema: from preclinical studies to phase 3 outcomes.
Graefes Arch Clin Exp Ophthalmol;
2024 Jun 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38847896
4.
A review of emerging tyrosine kinase inhibitors as durable treatment of neovascular age-related macular degeneration.
Expert Opin Emerg Drugs;
28(3): 203-211, 2023 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37796039
5.
Impact of an immersive, interactive medical education initiative on guideline-based retinal disease management knowledge/competence and effectual practice change.
BMC Ophthalmol;
23(1): 285, 2023 Jun 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37349689
6.
Brolucizumab for the treatment of diabetic macular edema.
Curr Opin Ophthalmol;
33(3): 167-173, 2022 May 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35266896
7.
EFFECT OF RETINAL THICKNESS VARIABILITY ON VISUAL OUTCOMES AND FLUID PERSISTENCE IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: A Post Hoc Analysis of the HAWK and HARRIER Studies.
Retina;
42(3): 511-518, 2022 03 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34923515
8.
Characterization of ophthalmic presentations to emergency departments in the United States: 2010-2018.
Am J Emerg Med;
54: 279-286, 2022 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35227958
9.
Patient Satisfaction in the Era of COVID-19: Virtual Visit versus In-person Visit Satisfaction.
Optom Vis Sci;
99(2): 190-194, 2022 02 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34889857
10.
Ocular occupational injuries in the United States between 2011-2018.
Occup Med (Lond);
72(4): 255-259, 2022 05 23.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35020942
11.
Racial, Ethnic, and Insurance-Based Disparities Upon Initiation of Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema in the US.
Ophthalmology;
128(10): 1438-1447, 2021 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33716048
12.
Characterizing New-Onset Exudation in the Randomized Phase 2 FILLY Trial of Complement Inhibitor Pegcetacoplan for Geographic Atrophy.
Ophthalmology;
128(9): 1325-1336, 2021 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33711380
13.
HAWK and HARRIER: Ninety-Six-Week Outcomes from the Phase 3 Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration.
Ophthalmology;
128(1): 89-99, 2021 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32574761
14.
Photobiomodulation therapy in age-related macular degeneration.
Curr Opin Ophthalmol;
32(3): 225-232, 2021 May 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33606405
15.
RETINAL FLUID AND THICKNESS AS MEASURES OF DISEASE ACTIVITY IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
Retina;
41(8): 1579-1586, 2021 Aug 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33949342
16.
THE ANGIOPOIETIN/TIE PATHWAY IN RETINAL VASCULAR DISEASES: A Review.
Retina;
41(1): 1-19, 2021 01 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33136975
17.
CONSEQUENCES OF LAPSES IN TREATMENT WITH VASCULAR ENDOTHELIAL GROWTH FACTOR INHIBITORS IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION IN ROUTINE CLINICAL PRACTICE.
Retina;
41(3): 581-587, 2021 Mar 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32658164
18.
Bariatric Surgery versus Intensive Medical Therapy for Diabetes - 5-Year Outcomes.
N Engl J Med;
376(7): 641-651, 2017 02 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28199805
19.
Effects of Quality Improvement Education in Diabetic Retinopathy on Routine Clinical Practice Patterns of Optometrists.
Optom Vis Sci;
97(11): 936-943, 2020 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33122498
20.
Undertreatment of Neovascular Age-Related Macular Degeneration after 10 Years of Anti-Vascular Endothelial Growth Factor Therapy in the Real World: The Need for A Change of Mindset.
Ophthalmologica;
243(1): 1-8, 2020.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31743912